The dual EGFR/HER2 inhibitor lapatinib synergistically enhances the antitumor activity of the histone deacetylase inhibitor panobinostat in colorectal cancer models

類似資料

• DNA microarray profiling of genes differentially regulated by the histone deacetylase inhibitors vorinostat and LBH589 in colon cancer cell lines
  著者:: LaBonte, Melissa J, 等
  出版事項: (2009)
• Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
  著者:: Collantes Maria, 等
  出版事項: (2010-05-01)
• Antitumor and antiangiogenic effect of the dual EGFR and HER-2 tyrosine kinase inhibitor lapatinib in a lung cancer model
  著者:: Diaz, Roque, 等
  出版事項: (2010)
• Regulation of human dUTPase gene expression and p53-mediated transcriptional repression in response to oxaliplatin-induced DNA damage
  著者:: Wilson, Peter M., 等
  出版事項: (2009)
• The Cyclin D1 (CCND1) A870G polymorphism predicts clinical outcome to lapatinib and capecitabine in HER2-positive metastatic breast cancer
  著者:: LaBonte, M. J., 等
  出版事項: (2012)